Effect of circulatory congestion on the components of pulmonary diffusing capacity in morbid obesity

Obesity

Volumn 14, Issue 7, 2006, Pages 1172-1180

  Oppenheimer, Beno W ^a,d   Berger, Kenneth I ^a   Rennert, Douglas A ^e   Pierson, Richard N ^c   Norman, Robert G ^a   Rapoport, David M ^a   Kral, John G ^b   Goldring, Roberta M ^a  

^a BELLEVUE HOSPITAL CENTER   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c Columbia University ^*  (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NONE

Author keywords

Blood volume; Cardiovascular diseases; Lung; Pulmonary diffusing capacity

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD GAS ANALYSIS; BLOOD VOLUME; BODY WATER; BREATHING; CAPILLARY PERMEABILITY; FEMALE; HUMAN; LUNG CIRCULATION; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; LUNG GAS EXCHANGE; LUNG VOLUME; MALE; METABOLISM; MORBID OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR RESISTANCE; WAIST HIP RATIO; WEIGHT REDUCTION;

ADOLESCENT; ADULT; BLOOD GAS ANALYSIS; BLOOD VOLUME; BODY WATER; CAPILLARY PERMEABILITY; FEMALE; HUMANS; LUNG VOLUME MEASUREMENTS; MALE; OBESITY, MORBID; PULMONARY CIRCULATION; PULMONARY DIFFUSING CAPACITY; PULMONARY GAS EXCHANGE; RESPIRATION; RESPIRATORY FUNCTION TESTS; VASCULAR RESISTANCE; WAIST-HIP RATIO; WEIGHT LOSS;

EID: 33846852870     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2006.134     Document Type: Article

References (53)

1. Alexander JK, Alpert MA. Pathogenesis and clinical manifestations of obesity cardiomyopathy. In: Alpert MA, Alexander JK, eds. The Heart and Lung in Obesity. Armonk, NY: Futura Publishing Company; 1998; pp. 133-45.
2. Kaltman AJ, Goldring RM. Role of circulatory congestion in the cardiorespiratory failure of obesity. Am J Med. 1976; 60:645-53.
3. Alpert MA. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci. 2001 ;321: 225-36.
4. Baylor P, Goebel P. Clinical correlates of an elevated diffusing capacity for carbon monoxide corrected for alveolar volume. Am J Med Sci. 1996;311:266-71.
5. Collard P, Wilputte JY, Aubert G, Rodenstein DO, Frans A. The single-breath diffusing capacity for carbon monoxide in obstructive sleep apnea and obesity. Chest. 1996; 110:1189-93.
6. Ray CS, Sue DY, Bray G, Hansen JE, Wasserman K. Effects of obesity on respiratory function. Am Rev Respir Dis. 1983;128:501-6.
7. Saydain G, Beck KC, Decker PA, Cowl CT, Scanlon PD. Clinical significance of elevated diffusing capacity. Chest. 2004; 125:446-52.
8. Roughton FJ, Forster RE. Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in the human lung, with special reference to true diffusing capacity of pulmonary membrane and volume of blood in the lung capillaries. J Appl Physiol. 1957; 11:290-302.
9. McNeil RS, Rankin J, Forster RE. The diffusing capacity of the pulmonary membrane and the pulmonary capillary blood volume in cardiopulmonary disease. Clin Sci. 1958;17:465-82.
10. Hsia CC. Recruitment of lung diffusing capacity: update of concept and application. Chest. 2002;122:1774-83.
11. Tamhane RM, Johnson RLJ, Hsia CC. Pulmonary membrane diffusing capacity and capillary blood volume measured during exercise from nitric oxide uptake. Chest. 2001; 120: 1850-6.
12. Hadjiangelis NP, Oppenheimer BW, Berger KI, et al. Heterogeneity and recruitability affect membrane diffusion (Dm) and capillary volume (Vc) in pulmonary vascular diseases. Am J Respir Crit Care Med. 2002;165:A96.
13. Puri S, Baker BL, Dutka DP, Oakley CM, Hughes JM, Cleland JG. Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure: its pathophysiological relevance and relationship to exercise performance. Circulation. 1995;91:2769-74.
14. Guazzi M, Pontone G, Brambilla R, Agostoni P, Reina G. Alveolar-capillary membrane gas conductance: a novel prognostic indicator in chronic heart failure. Eur Heart J. 2002; 23:467-76.
15. Guazzi M, Marenzi G, Alimento M, Contint M, Agostoni P. Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin. Circulation. 1997;95:1930-6.
16. Assayag P, Benamer H, Aubry P, et al. Alteration of the alveolar-capillary membrane diffusing capacity in chronic left heart disease. Am J Cardiol. 1998;82:459-64.
17. Mettauer B, Lampert E, Charloux A, et al. Lung membrane diffusing capacity, heart failure, and heart transplantation. Am J Cardiol. 1999;83:62-7.
18. Dubois AB, Bothello SY, Bedell GN, Marshall R, Comroe JH Jr. A rapid plethysmographic method for measuring thoracic gas volume. J Clin Invest. 1956;35:322-6.
19. American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med. 1995;152:1107-36.
20. Ogilvie CM, Forster RE, Blakemore WS, Morton JW. A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. J Clin Invest. 1957;36:1-17.
21. Dinakara P, Blumenthal WS, Johnston RF, Kauffman LA, Solnick PB. The effect of anemia on pulmonary diffusing capacity with derivation of a correction equation. Am Rev Respir Dis. 1970:102:965-9.
22. Johnson RL, Jr., Taylor, Degraff AC, Jr. Functional significance of a low pulmonary diffusing capacity for carbon monoxide. J Clin Invest. 1965;44:789-800.
23. Forster RE. Exchange of gases between alveolar air and pulmonary capillary blood: pulmonary diffusing capacity. Physiol Rev. 1957;37:391-452.
24. Krumholz RA. Pulmonary membrane diffusing capacity and pulmonary capillary blood volume: an appraisal of their clinical usefulness. Am Rev Respir Dis. 1966;94:195-200.
25. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis. 1983; 127:725-34.
26. Goldman HI, Becklake MR. Normal values at median altitudes and the prediction of normal results. Am Rev Tuberc. 1959;79:457-67.
27. Van Ganse WF, Ferris BGJ, Cotes JE. Cigarette smoking and pulmonary diffusing capacity (transfer factor). Am Rev Respir Dis. 1972;105:30-41.
28. Bucci G, Cook CD, Barrie H. Total lung diffusion, diffusing capacity of pulmonary membrane, and pulmonary capillary blood volume in normal subjects from 7 to 40 years of age. J Pediatr. 1961;58:820-8.
29. Pierson RNJ, Wang J, Colt EW, Neumann P. Body composition measurements in normal man: the potassium, sodium, sulfate and tritium spaces in 58 adults. J Chronic Dis. 1982; 35:419-28.
30. Mazariegos M, Krai JG, Wang J, et al. Body composition and surgical treatment of obesity: effects of weight loss on fluid distribution. Ann Surg. 1992;216:69-73.
31. Wang ZM, Pierson RNJ, Heymsfield SB. The five-level model: a new approach to organizing body-composition research. Am J Clin Nutr. 1992;56:19-28.
32. Waki M, Kral JG, Mazariegos M, Wang J, Pierson RNJ, Heymsfield SB. Relative expansion of extracellular fluid in obese vs. nonobese women. Am J Physiol. 1991;261:E199-203.
33. Alpert MA, Alexander JK, eds. The Heart and Lung in Obesity. Armonk, NY: Futura Publishing Company; 1998.
34. Rochester DF. Obesity and pulmonary function. In: Alpert MA, Alexander JK, eds. The Heart and Lung in Obesity. Armonk, NY: Futura Publishing Co.; 1998; pp. 109-31.
35. Amad KH, Brennan JC, Alexander JK. The cardiac pathology of chronic exogenous obesity. Circulation. 1965;32: 740-5.
36. Alexander JK, Pettigrove JR. Obesity and congestive heart failure. Geriatrics. 1967;22:101-8.
37. Backman L, Freyschuss U, Hallberg D, Melcher A. Cardiovascular function in extreme obesity. Acta Med Scand. 1973;193:437-46.
38. Alexander JK. Chronic heart disease due to obesity. J Chronic Dis. 1965;18:895-8.
39. Bosisio E, Sergi M, di Natale B, Chiumello G. Ventilatory volumes, flow rates, transfer factor and its components (membrane component, capillary volume) in obese adults and children. Respiration. 1984;45:321-6.
40. Peiris AN, Sothmann MS, Hoffmann RG, et al. Adiposity, fat distribution, and cardiovascular risk. Ann Intern Med. 1989;110:867-72.
41. Reeder B A, Senthilselvan A, Despres JP, et al. The association of cardiovascular disease risk factors with abdominal obesity in Canada: Canadian Heart Health Surveys Research Group. Can Med Assoc J. 1997;157(Suppl 1):S39-45.
42. Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Björntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed). 1984;288:1401-4.
43. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709-16.
44. Kannel WB, Cupples LA, Ramaswami R, Stokes J, Kreger BE, Higgins M. Regional obesity and risk of cardiovascular disease: the Framingham Study. J Clin Epidemiol. 1991;44: 183-90.
45. Guazzi M. Alveolar-capillary membrane dysfunction in heart failure: evidence of a pathophysiologic role. Chest. 2003; 124:1090-102.
46. Matthay MA, Folkesson HG, Verkman AS. Salt and water transport across alveolar and distal airway epithelia in the adult lung. Am J Physiol. 1996;270:L487-503.
47. +-pump regulation by insulin and leptin. Cell Mol Biol. 2001;47:363-72.
48. DeFronzo RA, Goldberg M, Agus ZS. The effects of glucose and insulin on renal electrolyte transport. J Clin Invest. 1976; 58:83-90.
49. DeFronzo RA. The effect of insulin on renal sodium metabolism: a review with clinical implications. Diabetologia. 1981;21:165-71.
50. Baum M. Insulin stimulates volume absorption in the rabbit proximal convoluted tubule. J Clin Invest. 1987;79: 1104-9.
51. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engt J Med. 2002;347:305-13.
52. Beltowski J, Wojcicka G, Marciniak A, Jamroz A. Ox idative stress, nitric oxide production, and renal sodium handling in leptin-induced hypertension. Life Sci. 2004;74: 2987-3000.
53. Kasper EK, Hruban RH, Baughman KL. Cardiomyopathy of obesity: a clinicopathologic evaluation of 43 obese patients with heart failure. Am J Cardiol. 1992:70:921-4.